Risks and Outcomes of Living Donation

Advances in Chronic Kidney Disease

Volumn 19, Issue 4, 2012, Pages 220-228

  Lentine, Krista L ^a,b,c   Patel, Anita ^a,b,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Henry Ford Transplant Institute   (United States)

Author keywords

Hypertension; Kidney failure; Kidney transplantation; Living donors; Mortality; Postoperative complications; Risk

Indexed keywords

AFRICAN AMERICAN; CAUCASIAN; CHRONIC KIDNEY FAILURE; COMORBIDITY; DATA BASE; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INFORMED CONSENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; LIVING DONOR; OBESITY; OUTCOMES RESEARCH; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; UNINEPHRECTOMY; UNITED STATES;

AFRICAN AMERICANS; DIABETES MELLITUS; HUMANS; HYPERTENSION; INFORMED CONSENT; INTRAOPERATIVE COMPLICATIONS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES;

EID: 84862834221     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.09.005     Document Type: Review

References (45)

1. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995, 333:333-336.
2. Klein A.S., Messersmith E.E., Ratner L.E., Kochik R., Baliga P.K., Ojo A.O. Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010, 10(4 Pt. 2):973-986.
3. OTPN/HRSA. National Data, Transplants by Donor Type. Available at: . Accessed June 1, 2011. http://optn.transplant.hrsa.gov/latestData/rptData.asp.
4. Brown R.S., Higgins R., Pruett T.L. The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States. Am J Transplant 2009, 9:31-34.
5. Graham W. Living donor follow-up data: status report from the OPTN 2008, Advisory Committee on Organ Transplantation (ACOT), Rockville, MD, Available at:. https://www.team-psa.com/DOT/ACOT2008/presentations.asp.
6. Ommen ES, Lapointe Rudow D, Medapalli RK, Schroppel B, Murphy B. When good intentions are not enough: obtaining follow-up data in living kidney donors. Am J Transplant. In press.
7. Segev D.L., Muzaale A.D., Caffo B.S., et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010, 303:959-966.
8. Lentine K.L., Schnitzler M.A., Xiao H., et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010, 363:724-732.
9. Lentine KL, Schnitzler MA, Xiao H, et al. Associations of recipient illness history with hypertension and diabetes after living kidney donation. Transplantation. In press.
10. Davis C.L., Cooper M. The state of U.S. living kidney donors. Clin J Am Soc Nephrol 2010, 5:1873-1880.
11. Ibrahim H.N., Foley R., Tan L., et al. Long-term consequences of kidney donation. N Engl J Med 2009, 360:459-469.
12. Colombo B., Singla A., Li Y., et al. Current trends and short-term outcomes of live donor nephrectomy: a population-based analysis of the nationwide inpatient sample. World J Surg 2010, 34:2985-2990.
13. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213.
14. Mjoen G., Oyen O., Holdaas H., Midtvedt K., Line P.D. Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry. Transplantation 2009, 88:1273-1279.
15. Patel S., Cassuto J., Orloff M., et al. Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation 2008, 85:561-565.
16. Permpongkosol S., Link R.E., Su L.M., et al. Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. J Urol 2007, 177:580-585.
17. Ommen E.S., Winston J.A., Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006, 1:885-895.
18. Center for Disease Control and Prevention. Death and Mortality (U.S.). Available at: . Accessed May 17, 2011. http://www.cdc.gov/nchs/fastats/deaths.htm.
19. World Health Organization. Mortality Country Fact Sheet 2006. Available at: . Accessed May 17, 2011. http://www.who.int/whosis/mort/profiles/mort_wpro_jpn_japan.pdf.
20. Okamoto M., Akioka K., Nobori S., et al. Short- and long-term donor outcomes after kidney donation: analysis of 601 cases over a 35-year period at Japanese single center. Transplantation 2009, 87:419-423.
21. Gibney E.M., King A.L., Maluf D.G., Garg A.X., Parikh C.R. Living kidney donors requiring transplantation: focus on African Americans. Transplantation 2007, 84:647-649.
22. Doshi M., Garg A.X., Gibney E., Parikh C. Race and renal function early after live kidney donation: an analysis of the United States Organ Procurement and Transplantation Network Database. Clin Transplant 2010, 24:E153-E157.
23. Cherikh W.S., Pan-Yen F., Taranto S.E. Prior living kidney donors who were subsequently placed on the waiting list: an updated OPTN analysis. Am J Transplant 2008, 8:335.
24. Genovese G., Friedman D.J., Ross M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
25. Reeves-Daniel A.M., Depalma J.A., Bleyer A.J., et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011, 11:1025-1030.
26. Kido R., Shibagaki Y., Iwadoh K., et al. How do living kidney donors develop end-stage renal disease?. Am J Transplant 2009, 9:2514-2519.
27. Nogueira J.M., Weir M.R., Jacobs S., et al. A study of renal outcomes in obese living kidney donors. Transplantation 2010, 90:993-999.
28. Garg A.X., Prasad G.V., Thiessen-Philbrook H.R., et al. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation 2008, 86:399-406.
29. Boudville N., Prasad G.V., Knoll G., et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006, 145:185-196.
30. Reese P.P., Feldman H.I., Asch D.A., Thomasson A., Shults J., Bloom R.D. Short-term outcomes for obese live kidney donors and their recipients. Transplantation 2009, 88:662-671.
31. Carter J.S., Pugh J.A., Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996, 125:221-232.
32. Cutler J.A., Sorlie P.D., Wolz M., Thom T., Fields L.E., Roccella E.J. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008, 52:818-827.
33. Storsley L.J., Young A., Rush D.N., et al. Long-term medical outcomes among Aboriginal living kidney donors. Transplantation 2010, 90:401-406.
34. Nogueira J.M., Weir M.R., Jacobs S., et al. A study of renal outcomes in African American living kidney donors. Transplantation 2009, 88:1371-1376.
35. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
36. Sarwar N., Gao P., Seshasai S.R., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
37. Steiner R.W. 'Normal for now' or 'at future risk': a double standard for selecting young and older living kidney donors. Am J Transplant 2010, 10:737-741.
38. Textor S.C. Age before beauty: using stratified selection criteria for living kidney donors (Viewpoint). Nephrol Times 2011, 4(1):13-14. 10.1097/1001.NEP. 0000394217.0000340483.0000394229.
39. Delmonico F. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005, 79(suppl 6):S53-S66.
40. Reeves-Daniel A, Bailey A, Assimos D, et al. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant. In press.
41. Reisaeter A.V., Roislien J., Henriksen T., Irgens L.M., Hartmann A. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant 2009, 9:820-824.
42. Ibrahim H.N., Akkina S.K., Leister E., et al. Pregnancy outcomes after kidney donation. Am J Transplant 2009, 9:825-834.
43. Mandelbrot D.A., Pavlakis M., Karp S.J., Johnson S.R., Hanto D.W., Rodrigue J.R. Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers. Transplantation 2009, 88:855-860.
44. Assessing Long Term Outcomes after Living Kidney Donation (ALTOLD). Available at: . Accessed July 21, 2011. http://www.kidney.org/nkfmb/messages.cfm?fthreadid=72D54382-17A4-8D04-9487CA5F4A474487.
45. Renal and Lung Living donors Evaluation (RELIVE) Study. Available at: . Accessed July 21, 2011. http://nih-livingdonor.org/.